Free Trial

ClearPoint Neuro (CLPT) SEC Filings & 10K Form

ClearPoint Neuro logo
$16.72 -0.73 (-4.18%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$16.73 +0.01 (+0.06%)
As of 02/21/2025 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ClearPoint Neuro SEC Filings

DateFilerForm TypeView
01/29/2025
3:30 PM
BIGGER CAPITAL FUND L P (Filed by)
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro (Subject)
Form SCHEDULE 13G/A
01/03/2025
3:51 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Richards Timothy T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:54 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
LIAU LINDA M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:57 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:45 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Girin Pascal E R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:48 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
1:35 PM
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
4:00 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 424B5
11/07/2024
4:02 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:28 AM
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/11/2024
4:03 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
3:22 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:45 PM
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro (Subject)
PTC THERAPEUTICS, INC. (Filed by)
Form SC 13D/A
08/07/2024
4:16 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/02/2024
4:23 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:25 PM
BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:26 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:26 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:19 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Richards Timothy T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:20 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:21 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Girin Pascal E R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:22 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
LIAU LINDA M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:31 PM
BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:32 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:32 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:38 PM
BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:39 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:39 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:40 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:04 AM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
8:16 AM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Richards Timothy T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:17 AM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
LIAU LINDA M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:18 AM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
JOHNSON B KRISTINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:19 AM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Klein Matthew B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:19 AM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Girin Pascal E R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:20 AM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
8:21 AM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FALLON LYNNETTE C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
4:17 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:05 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
3:34 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form DEF 14A
04/02/2024
3:44 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
FLETCHER R JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Collect $7k per month from Tesla’s SECRET dividend (Ad)

There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?

Click here to uncover Tesla's hidden income secret.
03/13/2024
3:51 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:52 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:17 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2024
3:39 PM
BURNETT JOSEPH MICHAEL (Reporting)
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:40 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
D'Alessandro Danilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:40 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:41 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
SABRA MAZIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
3:05 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
7:00 AM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/28/2024
3:05 PM
ClearPoint Neuro, Inc. (Filer)
ClearPoint Neuro (Filer)
Form 424B5
02/23/2024
5:12 PM
ClearPoint Neuro, Inc. (Issuer)
ClearPoint Neuro (Issuer)
STIGALL L. JEREMY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CLPT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners